SCHEMBL30718241

SCHEMBL30718241

CC(C)(C)OC(=O)N1CCN(c2nccc(-c3cc4ccccc4n3C(=O)OC(C)(C)C)n2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.55
▸ NR1H2 P55055 9/20 0.48
▸ CHRNA7 P36544 1/20 0.47
▸ GPR119 Q8TDV5 1/20 0.47
▸ PTPN11 Q06124 1/20 0.46
▸ DDB1 Q16531 1/20 0.46
▸ CRBN Q96SW2 1/20 0.46
▸ NR1H3 Q13133 3/20 0.46
▸ TRPV3 Q8NET8 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ SMARCA2 P51531 1/20 0.45
▸ SMARCA4 P51532 1/20 0.45
▸ PBRM1 Q86U86 1/20 0.45
▸ CA12 O43570 1/20 0.45
▸ CA9 Q16790 1/20 0.45
▸ CKS1B P61024 1/20 0.45
▸ SKP1 P63208 1/20 0.45
▸ SKP2 Q13309 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30718171 0.89 NR1H2 (0.48) ACHENR1H2NR1H3TRPV3CA12
SCHEMBL3274585 0.81 ACHE (0.66) ACHECHRNA7GPR119PTPN11DDB1
SCHEMBL3651086 0.81 ACHE (0.57) ACHECHRNA7GPR119PTPN11DDB1
SCHEMBL27029442 0.78 ACHE (0.55) ACHECHRNA7GPR119PTPN11DDB1
SCHEMBL30718211 0.78 ACHE (0.55) ACHECHRNA7GPR119PTPN11DDB1
SCHEMBL27029449 0.78 ACHE (0.54) ACHECHRNA7GPR119PTPN11DDB1
SCHEMBL3268731 0.78 ACHE (0.58) ACHECHRNA7GPR119PTPN11DDB1
SCHEMBL30619487 0.78 NR1H2 (0.64) NR1H2NR1H3TRPV3CA12CA9
SCHEMBL30831452 0.77 ACHE (0.57) ACHECHRNA7GPR119PTPN11DDB1
SCHEMBL26993891 0.77 ACHE (0.57) ACHECHRNA7GPR119PTPN11DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117157284-A CTLA-4 small molecule degradation agent and application thereof 苏州国匡医药科技有限公司 2023-12-01 — — CN disclosed
Send feedback